Terumo Neuro has launched the Sofia Flow 88 large-bore aspiration catheter, designed for supporting clot removal in stroke ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the commercial availability of the Sofia Flow 88 ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and ...

Orange County’s largest private companies experienced continued growth last year, primarily driven by mergers and ...

Terumo Interventional Systems (TIS), a division of Terumo Corporation, is pleased to announce the early commercial availability of its FDA-approved ROADSAVERtm Carotid Stent System. Indicated for use ...

Terumo Neuro (formerly MicroVention) has launched the SOFIA 88 Neurovascular Support Catheter commercially in the US, making a new addition to its stroke portfolio. The large-bore catheter is ...

Neuro and Aortic led the way. Profits also increased significantly due to increased revenues and various other measures. Next slide, please. Turning next is TMCS, Terumo Medical Care Solutions.